NovoCure falls below reduced IPO price in market debut
October 02, 2015 at 18:12 PM EDT
Shares in oncology company NovoCure Ltd. fell sharply in their trading debut Friday, the latest example of investors’ waning appetite for biotechnology shares and for initial public offerings.
